Sulfate ion

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Sulfate ion
Accession Number
DB14546
Description
Not Available
Type
Small Molecule
Groups
Experimental, Investigational
Structure
Thumb
Weight
Average: 96.063
Monoisotopic: 95.951729178
Chemical Formula
O4S
Synonyms
  • Sulfate
  • Sulfate dianion
  • Sulfate(2-)
  • Sulfuric acid ion(2-)

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Sulfate ion.
AclidiniumThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Aclidinium.
AlfentanilThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Alfentanil.
AlloinThe risk or severity of adverse effects can be increased when Sulfate ion is combined with Alloin.
AlmasilateThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Almasilate.
AluminiumThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Aluminium.
Aluminium phosphateThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Aluminium phosphate.
Aluminum hydroxideThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Aluminum hydroxide.
AmantadineThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Amantadine.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Sulfate ion.
Additional Data Available
  • Extended Description
    Extended Description
    Available for Purchase

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity
    Available for Purchase

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level
    Available for Purchase

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action
    Available for Purchase

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Purchasing individual compounds or compound libraries for your research?
Learn More
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Loa Freedom SCapsule100 g/1001OralLOA BIO INC.2020-11-09Not applicableUS flag
Additional Data Available
  • Application Number
    Application Number
    Available for Purchase

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code
    Available for Purchase

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
RurinaSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalTELOM-X GENE Co., Ltd.2017-07-01Not applicableUS flag
RurinaSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalNano Bio Tech Co.,Ltd2017-07-01Not applicableUS flag
Telom-X-geneSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalTELOM-X GENE Co., Ltd.2017-07-01Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Loa Freedom SSulfate ion (100 g/1001)CapsuleOralLOA BIO INC.2020-11-09Not applicableUS flag
RurinaSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalTELOM-X GENE Co., Ltd.2017-07-01Not applicableUS flag
RurinaSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalNano Bio Tech Co.,Ltd2017-07-01Not applicableUS flag
Telom-X-geneSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalTELOM-X GENE Co., Ltd.2017-07-01Not applicableUS flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
7IS9N8KPMG
CAS number
14808-79-8
InChI Key
QAOWNCQODCNURD-UHFFFAOYSA-L
InChI
InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2
IUPAC Name
sulfate
SMILES
[O-]S([O-])(=O)=O

References

General References
Not Available
Human Metabolome Database
HMDB0001448
ChemSpider
1085
BindingDB
26992
RxNav
1426598
ChEBI
16189
PDBe Ligand
SO4
Wikipedia
Sulfate
PDB Entries
101m / 102m / 103m / 104m / 105m / 106m / 107m / 108m / 109m / 110m
show 20965 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedDiagnosticCathartic Colon1
4CompletedTreatmentInflammatory Bowel Diseases (IBD) / Iron Deficiency1
4Not Yet RecruitingTreatmentAnemia of Prematurity / Very Low Birth Weight Infant1
4RecruitingTreatmentChronic Kidney Disease (CKD) / Kidney Insufficiency, Chronic1
4Unknown StatusDiagnosticColonoscopy1
4Unknown StatusDiagnosticPreeclampsia1
4Unknown StatusTreatmentDeep Neuromuscular Blockade / Magnesium Sulfate / Neuromuscular Blockade / Rocuronium1
4Unknown StatusTreatmentInflammatory Bowel Diseases (IBD) / Iron Deficiency Anemia (IDA)1
4Unknown StatusTreatmentIron Deficiency Anemia (IDA) / Iron-Deficiency Anemias / Pregnancy1
3Active Not RecruitingTreatmentAcute Lymphoblastic Leukaemias (ALL) / Acute Undifferentiated Leukemia (AUL) / Childhood T Acute Lymphoblastic Leukemia / Untreated Childhood Acute Lymphoblastic Leukemia1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CapsuleOral100 g/1001
LiquidTopical
SolutionIntravenous12 g/L
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-0.84ChemAxon
pKa (Strongest Acidic)-3ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area80.26 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity11.53 m3·mol-1ChemAxon
Polarizability5.81 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created on July 12, 2018 15:40 / Updated on June 12, 2020 10:53

Logo pink
Are you a data scientist
working on drug development?
DrugBank has a breadth of high quality data, organized and structured to support drug development research.